Erythropoietin improves skin wound healing and activates the TGF-Β signaling pathway

Laboratory Investigation

Volumn 91, Issue 12, 2011, Pages 1753-1765

  Siebert, Nikolai ^a   Xu, Weiguo ^a   Grambow, Eberhard ^a   Zechner, Dietmar ^a   Vollmar, Brigitte ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

epithelialization; kin wound repair; mad proteins; xtracellular matrix

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ERYTHROPOIETIN RECEPTOR; MESSENGER RNA; NEUTRALIZING ANTIBODY; RECOMBINANT ERYTHROPOIETIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DRUG MECHANISM; EPITHELIZATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; SKIN INJURY; UPREGULATION; WESTERN BLOTTING; WOUND CLOSURE; WOUND HEALING;

ACTINS; ANIMALS; CELL LINE; CELL MIGRATION ASSAYS; ERYTHROPOIETIN; FIBROBLASTS; KERATINOCYTES; MICE; RECEPTORS, ERYTHROPOIETIN; RNA, MESSENGER; SKIN; TRANSFORMING GROWTH FACTOR BETA1; WOUND HEALING;

EID: 82355181387     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.125     Document Type: Article

References (36)

1. Jelkmann W. Biology of erythropoietin. Clin Invest 1994;72:S3-S10. (Pubitemid 24208372)
2. Arcasoy MO. The non-haematopoietic biological effects of erythropoietin. Br J Haematol 2008;141:14-31. (Pubitemid 351347536)
3. Youssoufian H, Longmore G, Neumann D, et al. Structure, function, and activation of the erythropoietin receptor. Blood 1993;81:2223-2236. (Pubitemid 23127056)
4. Ogilvie M, Yu X, Nicolas-Metral V, et al. Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts. J Biol Chem 2000;275:39754-39761. (Pubitemid 32059005)
5. Galeano M, Altavilla D, Bitto A, et al. Recombinant human erythropoietin improves angiogenesis and wound healing in experimental burn wounds. Crit Care Med 2006;34:1139-1146.
6. Brines M, Cerami A. Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J Intern Med 2008;264:405-432.
7. Haroon ZA, Amin K, Jiang X, et al. A novel role for erythropoietin during fibrin-induced wound-healing response. Am J Pathol 2003;163: 993-1000. (Pubitemid 37040135)
8. Sorg H, Krueger C, Schulz T, et al. Effects of erythropoietin in skin wound healing are dose related. FASEB J 2009;23:3049-3058.
9. Hamed S, Ullmann Y, Masoud M, et al. Topical erythropoietin promotes wound repair in diabetic rats. J Invest Dermatol 2010;130:287-294.
10. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003;83:835-870. (Pubitemid 36828927)
11. Barrientos S, Stojadinovic O, Golinko MS, et al. Growth factors and cytokines in wound healing. Wound Repair Regen 2008;16:585-601.
12. Li J, Zhang YP, Kirsner RS. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc Res Tech 2003; 60:107-114. (Pubitemid 36055239)
13. Ashcroft GS, Roberts AB. Loss of Smad3 modulates wound healing. Cytokine Growth Factor Rev 2000;11:125-131. (Pubitemid 30169733)
14. Derynck R, Zhang Y, Feng XH. Smads: transcriptional activators of TGF-beta responses. Cell 1998;95:737-740. (Pubitemid 29014453)
15. Massagué J. TGF-beta signal transduction. Annu Rev Biochem 1998;67:753-791.
16. Hayashi H, Abdollah S, Qiu Y, et al. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 1997;89:1165-1173. (Pubitemid 127678749)
17. Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 2007;127:526-537.
18. Matrisian LM. The matrix-degrading metalloproteinases. Bioessays 1992;14:455-463.
19. Bodó E, Kromminga A, Funk W, et al. Human hair follicles are an extrarenal source and a nonhematopoietic target of erythropoietin. FASEB J 2007;21:3346-3354. (Pubitemid 47565553)
20. Selzer E, Wacheck V, Kodym R, et al. Erythropoietin receptor expression in human melanoma cells. Melanoma Res 2000;10:421-426.
21. Gold LI, Sung JJ, Siebert JW, et al. Type I (RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repair. Am J Pathol 1997;150:209-222. (Pubitemid 27027111)
22. O'Kane S, Ferguson MW. Transforming growth factor bs and wound healing. Int J Biochem Cell Biol 1997;29:63-78. (Pubitemid 27096420)
23. Schmid P, Cox D, Bilbe G, et al. TGF-beta s and TGF-beta type II receptor in human epidermis: differential expression in acute and chronic skin wounds. J Pathol 1993;171:191-197.
24. Schmid P, Itin P, Cherry G, et al. Enhanced expression of transforming growth factor-beta type I and type II receptors in wound granulation tissue and hypertrophic scar. Am J Pathol 1998;152: 485-493. (Pubitemid 28106395)
25. Cutroneo KR. TGF-beta-induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring. Wound Repair Regen 2007;1:S54-S60. (Pubitemid 47301675)
26. Yu H, Mrowietz U, Seifert O. Downregulation of SMAD2, 4 and 6 mRNA and TGFbeta receptor I mRNA in lesional and non-lesional psoriatic skin. Acta Derm Venereol 2009;89:351-356.
27. Dong C, Zhu S, Wang T, et al. Deficient Smad7 expression: a putative molecular defect in scleroderma. Proc Natl Acad Sci USA 2002;99:3908-3913. (Pubitemid 34252204)
28. Han KH, Choi HR, Won CH, et al. Alteration of the TGF-beta/SMAD pathway in intrinsically and UV-induced skin aging. Mech Ageing Dev 2005;126:560-567.
29. Reisdorf P, Lawrence DA, Sivan V, et al. Alteration of transforming growth factor-beta1 response involves down-regulation of Smad3 signaling in myofibroblasts from skin fibrosis. Am J Pathol 2001;159:263-272. (Pubitemid 33704211)
30. Ashcroft GS, Yang X, Glick AB, et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1999;1:260-266. (Pubitemid 129495775)
31. Arany PR, Flanders KC, Kobayashi T, et al. Smad3 deficiency alters key structural elements of the extracellular matrix and mechanotransduction of wound closure. Proc Natl Acad Sci USA 2006;103:9250-9255. (Pubitemid 43902564)
32. Nakao A, Afrakhte M, Morén A, et al. Identification of Smad7, a TGFbetainducible antagonist of TGF-beta signalling. Nature 1997;389:631-635. (Pubitemid 27446184)
33. Reynolds LE, Conti FJ, Silva R, et al. alpha3beta1 integrin-controlled Smad7 regulates reepithelialization during wound healing in mice. J Clin Invest 2008;118:965-974. (Pubitemid 351364604)
34. Desmoulière A, Geinoz A, Gabbiani F, et al. Transforming growth factor-beta 1 induces a-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993;122:103-111. (Pubitemid 23188802)
35. Rønnov-Jessen L, Petersen OW. Induction of a-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest 1993;68:696-707. (Pubitemid 23202798)
36. Reynolds LE, Conti FJ, Lucas M, et al. Accelerated re-epithelialization in beta3-integrin-deficient-mice is associated with enhanced TGF-beta1 signaling. Nat Med 2005;11:167-174. (Pubitemid 40321352)